Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial sponsored by Peking University is evaluating the effects of lutein and zeaxanthin supplementation on age-related macular degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein (lutein)
  • Zeaxanthin (Zeaxanthin)

Snippet

Sponsor: Peking University | Conditions: Age-related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN